SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP ANTI-HBS2 (AHBS2) ASSAY; AHBS IMMUNOASSAY,
|
Back to Search Results |
|
Model Number N/A |
Device Problem
No Apparent Adverse Event (3189)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 11/11/2018 |
Event Type
malfunction
|
Manufacturer Narrative
|
The cause for the (b)(6) advia centaur xp anti-hbs2 (ahbs2) result(s) is being investigated by siemens.
|
|
Event Description
|
The customer observed a (b)(6) patient result on a new reagent lot (119096) received.The (b)(6) result was considered to be discordant compared to a (b)(6) repeat result, and the patient's clinical history.The customer has reported observing this issue on other patient samples where (b)(6) results were not confirmed to be (b)(6) based the patient's clinical history, other (b)(6) markers, or repeat (b)(6) alternate (b)(6) test method results.Result information for the other patients has not been provided.The customer stated that no discordant (b)(6) results have been reported to physicians, and the results reported have not been questioned.There are no reports that treatment was altered or prescribed or adverse health consequences due to the discordant advia centaur xp (b)(6) result.
|
|
Manufacturer Narrative
|
Siemens filed mdr on (b)(6) 2018for a non-reproduced false positive advia centaur xp anti-hbs2 (ahbs2) patient result.01/11/2019 additional information: siemens has completed the incident investigation.Based on the information provided, the cause of the non-reproduced false positive advia centaur xp anti-hbs2 (ahbs2) patient result is unknown, and appears to be a site specific issue.A review of complaints was performed, and there were no other similar complaints found regarding imprecision for reagent lots 119094 and 119096.The advia centaur xp anti-hbs2 reagent lots 119094 and 119096 are performing as intended.No further evaluation of the device is required.
|
|
Search Alerts/Recalls
|
|
|